As to why, Price said the jury is still out. “Our patients were not healthier. They had the same co-morbidities as everywhere else in the country. But I think it’s because we developed a totally unbiased protocol. We based our judgment calls on who and when to give the drug based on specific threshold criteria,… Read More »
FRIDAY, May 29, 2020 (HealthDay News) — For men with advanced prostate cancer, a new hormone therapy pill works better than standard injections — and carries a much lower risk of heart attack or stroke, a clinical trial has found. The drug, called relugolix, is not yet approved by the U.S. Food and Drug Administration.… Read More »
A new type of test that uses complex sugars to detect prostate cancer earlier and with greater accuracy is being developed by researchers at the University of Birmingham. The test works by identifying sugars, known as glycans, in blood. These sugars are attached to protein molecules called PSA and are known to undergo distinct but… Read More »
After years of having the previously untreated liver cancer market all to itself, Bayer’s Nexavar is getting its first major competition—and it’s coming from Roche’s Tecentriq. The FDA Friday cleared a combination of the checkpoint inhibitor and fellow Roche med Avastin for previously untreated patients with hepatocellular carcinoma, the most common form of the disease.… Read More »
Lung cancer is a condition whereby cells in the lungs begin to divide uncontrollably to form a tumour – a mass of diseased or abnormal cells. Lung cancer doesn’t usually produce any symptoms in the early stages, but as the cancer begins too spread into neighbouring areas, warning signs tend to appear. One common warning… Read More »
Cancer patients have seen the world collapsing before their eyes, and then comes a pandemic. The American Society of Clinical Oncology estimates that this year there will be five thousand new cases of cancer per day in the United States, and COVID-19 adds another layer of worry for people with illnesses such as cancer and… Read More »